Spoken Alpha · Executive

Daniel E Geffken

Interim CFOCALCCalciMedica, Inc.

In our data from Mar 20, 2023

No earnings-call appearances indexed yet.

Role timeline

CALCCalciMedica, Inc.
Interim CFO
Mar 20, 2023 – May 17, 2024 · source: edgar_form4
PMNProMIS Neurosciences Inc.
Chief Financial Officer
Jul 7, 2022 – Oct 26, 2023 · source: edgar_form4
ELOXEloxx Pharmaceuticals, Inc.
INTERIM CFO
Nov 29, 2021 – Nov 29, 2021 · source: edgar_form4
CEROCERO THERAPEUTICS HOLDINGS, INC.
Chief Financial Officer
Oct 5, 2021 – Feb 14, 2024 · source: edgar_form4
CEROWCERO THERAPEUTICS HOLDINGS, INC.
Chief Financial Officer
Oct 5, 2021 – Feb 14, 2024 · source: edgar_form4
ELOXEloxx Pharmaceuticals, Inc.
CHIEF FINANCIAL OFFICER
Apr 20, 2021 – Apr 20, 2021 · source: edgar_form4
ELOXEloxx Pharmaceuticals, Inc.
Chief Financial Officer
Apr 1, 2021 – Apr 1, 2021 · source: edgar_form3

Research tier

See how this executive's language deviates from their own baseline

Sign in to view the per-call Behavioral Lean, the language-deviation timeline, and the novel forward-guidance phrases flagged across this executive's earnings calls — each scored against their own prior-call history.

Sign in to view Request research access

Call appearances in our data

No earnings-call appearances indexed for this executive yet.